Venkatesh Kundumani-Sridharan

Employment

• Quantum Biology Institute Head of Redox Biology and Metabolism
  2026 - Present
• Saturnus Bio Scientific Consultant & Advisor
  2025 - 2026
• Bristol-Myers Squibb (United States) Associate Director
  2024 - 2025
• Bristol-Myers Squibb (United States) Senior Principal Scientist
  2023 - 2024
• Bristol-Myers Squibb (United States) Principal Scientist
  2022 - 2023
• Bristol-Myers Squibb Senior Scientist
  2020 - 2022
• Texas Tech University Health Sciences Center Assistant Professor
  2018 - 2020
• University of Texas Health Science Center Assistant Professor
  2016 - 2018
• Texas Tech University Health Sciences Center Assistant Professor
  2012 - 2016
• University of Tennessee Health Science Center Assistant Professor
  2008 - 2012
• Louisiana State University Health Sciences Center Postdoctoral Research Associate
  2007 - 2008
• University of Tennessee Health Science Center Postdoctoral Fellow
  2005 - 2007

Education

• Central Food Technological Research Institute CSIR PhD
  ? - 2007
• Central Food Technological Research Institute CSIR MSc (Food Technology)
  ? - 2000
• Madurai Kamaraj University BSc (Industrial Microbiology)
  ? - 1998

Projects & Funding

Projects & funding information is unavailable.

Publications (41)

• Nrg1β Released in Remote Ischemic Preconditioning Improves Myocardial Perfusion and Decreases Ischemia/Reperfusion Injury via ErbB2-Mediated Rescue of Endothelial Nitric Oxide Synthase and Abrogation of Trx2 Autophagy.
  Arteriosclerosis, thrombosis, and vascular biology 2021 DOI: 10.1161/atvbaha.121.315957
  +Save
• Chaperone-Mediated Autophagy of eNOS in Myocardial Ischemia-Reperfusion Injury.
  Circulation research 2021 DOI: 10.1161/circresaha.120.317921
  +Save
• Thioredoxin Decreases Anthracycline Cardiotoxicity, But Sensitizes Cancer Cell Apoptosis.
  Cardiovascular toxicology 2020 DOI: 10.1007/s12012-020-09605-2
  +Save
• Thioredoxin protects mitochondrial structure, function and biogenesis in myocardial ischemia-reperfusion via redox-dependent activation of AKT-CREB- PGC1α pathway in aged mice.
  Aging 2020 DOI: 10.18632/aging.104071
  +Save
• Short-duration hyperoxia causes genotoxicity in mouse lungs: protection by volatile anesthetic isoflurane.
  American journal of physiology. Lung cellular and molecular physiology 2019 DOI: 10.1152/ajplung.00142.2018
  +Save
• Role of Thioredoxin in Age-Related Hypertension.
  Current hypertension reports 2018 DOI: 10.1007/s11906-018-0815-9
  +Save
• Thioredoxin reverses age-related hypertension by chronically improving vascular redox and restoring eNOS function.
  Science translational medicine 2017 DOI: 10.1126/scitranslmed.aaf6094
  +Save
• Thioredoxin Uses a GSH-independent Route to Deglutathionylate Endothelial Nitric-oxide Synthase and Protect against Myocardial Infarction.
  The Journal of biological chemistry 2016 DOI: 10.1074/jbc.m116.745034
  +Save
• Thioredoxin activates MKK4-NFκB pathway in a redox-dependent manner to control manganese superoxide dismutase gene expression in endothelial cells
  Journal of Biological Chemistry 2015 DOI: 10.1074/jbc.M115.660365
  +Save
• NFATc1 mediates Pak1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall remodeling
  Faseb Journal 2014
  +Save